Arcosa, Inc.
ACA · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $5 | $4 | $4 | $5 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $6 | $6 | $5 | $6 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 8.3% | 16.6% | -5.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 24.1% | 22.5% | 19.8% | 19.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 21.4% | 21% | 17.6% | 15.9% |
| Net Income | $0 | $0 | $0 | -$0 |
| % Margin | 9.2% | 8.1% | 3.7% | -1.2% |
| EPS Diluted | 1.48 | 1.22 | 0.48 | -0.16 |
| % Growth | 21.3% | 154.2% | 400% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |